Table 1.

Patients’ characteristics

	Group A (3 drugs)	Group B (2 drugs)	p
Age
Median (range), years	61 (29–79)	68 (32–84)
Sex
M	138	128	0.64
F	78	81
ECOG PS
0–1	165	155	0.67
2	51	54
Histotype
Intestinal	127	133	0.36
Diffuse	89	76
Site of primary tumor
Gastroesophageal junction	34	43	0.24
Stomach	182	166
Surgery
Yes	180	143	0.0005
No	36	66
Neoadjuvant/Adjuvant chemotherapy
Yes	74	62
No	142	147	0.36
Metastatic site
1	129	134	0.18
≥2	87	75
Peritoneal carcinosis
Yes	118	97	0.9
No	98	112
Second line chemotherapy
Yes	92	99	0.37
No	124	110